Early start of urate-lowering therapy improves serum urate control: results from a large national primary care cohort

The authors aimed to identify factors associated with long-term serum urate control in gout patients and to describe treatment patterns within a large national primary care cohort. They found that early initiation of urate-lowering therapy (ULT) and better adherence significantly improved serum urate control, yet only 12.4% of patients achieved good control, highlighting the need for enhanced management strategies in gout care.